EPO Patents = 4

Forward Citations = 8

Loading Chart...

6 inventors (with patents filed for the assignee):

Duncan Alexander Hay (6 out of 10 patents)

Thomas Beauregard Schofield (6 out of 11 patents)

Naomi Went (5 out of 9 patents)

4. Jonathan David Hargrave (4 out of 12 patents)

5. Clive McCarthy (4 out of 24 patents)

6. Clive Mccarthy (2 out of 11 patents)

6 patents: Sort by Forward Citations

1. 12371436 - Substituted benzodiazoliums as ENaC inhibitors (2025-07-29),

2. 12037336 - Compounds with activity as inhibitors of the epithelial sodium channel (ENaC) (2024-07-16),

3. 11739094 - Substituted benzodiazoliums as ENaC inhibitors (2023-08-29),

4. 11370778 - Bis(pentahydroxyhexyl)amino substituted 2-{[(3-amino-pyrazin-2-yl)formamido]methyl}-1H-1,3-benzodiazol-3-ium derivatives as ENaC inhibitors for treating respiratory diseases (2022-06-28),

5. 10941149 - Substituted benzodiazoliums as ENaC inhibitors (2021-03-09),

6. 10759785 - Compounds (2020-09-01),

Company Overview

Enterprise Therapeutics Limited is a UK-based biotechnology company focused on developing novel therapies for respiratory diseases. Their innovative approach targets the underlying mechanisms of disease to provide improved treatments for patients. With a strong emphasis on research and development, Enterprise Therapeutics is dedicated to making a meaningful impact on the lives of those affected by respiratory conditions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

6 Patents

#1 in Falmer

#2,679 in United Kingdom

Falmer, United Kingdom

Enterprise Therapeutics Limited

Forward Citations = 8

6 inventors:

Duncan Alexander Hay (6 out of 10 patents)

Thomas Beauregard Schofield (6 out of 11 patents)

Naomi Went (5 out of 9 patents)

4. Jonathan David Hargrave (4 out of 12 patents)

5. Clive McCarthy (4 out of 24 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Enterprise Therapeutics Limited. Retrieved from https://idiyas.com/company/enterprise-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

4 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]